(Q40652007)

22 September 2017

1 reference

title

Tourette syndrome. Secondary tic disorders (English)

1 reference

22 September 2017

Kumar R

1

1 reference

PubMed ID

9115464

22 September 2017

Lang AE

series ordinal

2

1 reference

22 September 2017

1 May 1997

1 reference

22 September 2017

1 reference

22 September 2017

15

1 reference

22 September 2017

309-331

1 reference

22 September 2017

2

1 reference

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cocaine induced chronic tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourette's syndrome and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Effect of carbamazepine on dopamine release and reuptake in rat striatal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tardive tourettism after exposure to neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Complex movement disorders induced by fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Pemoline induced chorea and Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Test of dopamine-blocking potential of clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Opiate therapy and self-harming behavior in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Does the use of phenobarbital as an anticonvulsant permanently exacerbate hyperactivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Anticonvulsant medications: an iatrogenic cause of tic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Trial of chlorimipramine and desipramine for gilles de la tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cocaine-related movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Clinical and genetic relationships between autism-pervasive developmental disorder and Tourette syndrome: a study of 19 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Hypothesis: homozygosity in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tics and Gilles de la Tourette's syndrome: a follow-up study and critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Eye tics and subjective hearing impairment during fluoxetine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tics following methylphenidate administration. A report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tardive Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Neuroanatomy of Gilles de la Tourette's Syndrome Possible Midbrain Involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Pseudo-tics in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Episodic Tourette's syndrome in a patient with citrullinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Fluoxetine and tics in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The relationship between eye-winking tics, frequent eye-blinking and blepharospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette's syndrome: effects of stimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles De La Tourette's Syndrome. Two cases with an organic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A new hereditary acanthocytosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cocaine and Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Effects of Dopamine Agonists and Antagonists in Tourette's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Neurological findings in patients with the fragile-X syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Huntington's disease: recent advances in diagnosis and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Fluoxetine in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Sydenham's chorea: magnetic resonance imaging of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The effect of central nervous system stimulants on tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Phenytoin and dyskinesias: a report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Sertraline-induced exacerbation of tics in Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Partial trisomy 16p in an adolescent with autistic disorder and Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A trigger for Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Clozapine in tardive Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourettism associated with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Increase of Parkinson disability after fluoxetine medication

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and theoretical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette's syndrome in Down's syndrome--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A second visually impaired, mentally retarded male with pervasive developmental disorder, Tourette disorder and Ganser's syndrome: diagnostic classification and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Asperger's syndrome and Tourette syndrome: the case of the pinball wizard

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Huntington disease and childhood-onset Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette syndrome after long-term chlorpromazine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Carbamazepine-induced tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Psychogenic movement disorder (pseudo-tics) in a patient with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Bilineal transmission in Tourette's syndrome families

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A case of Gilles de la Tourette's syndrome with midbrain involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Spasmodic dysphonia in Gilles de la Tourette's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Pure psychic akinesia with bilateral lesions of basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Elevated CSF dynorphin A [1-8] in Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A clinical study of Gilles de la Tourette syndrome in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Duchenne muscular dystrophy and Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Clinical evidence of genomic imprinting in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tic-like syndrome after treatment with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Coprolalia associated with hemiballismus: response to tetrabenazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Sequential use of opioid antagonists and agonists in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tic disorder associated with encephalopathy in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A Case of Multiple Tics with Vocalisation (Partial Syndrome of Gilles de la Tourette) and XYY Karyotype

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Methadone treatment of Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette's disorder associated with pemoline

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Lecithin in the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourette-like syndrome after long-term neuroleptic drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tardive Tourette's syndrome treated with clonidine and mesoridazine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Complex tics, stereotypies, and compulsive behavior as clinical presentation of a juvenile progressive dystonia suggestive of Hallervorden-Spatz disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Sydenham chorea: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Postencephalitic acquired Tourette-like syndrome in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cocaine-associated multifocal tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cholinergic treatment in the Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Carbamazepine-induced tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Hallervorden Spatz disease. Its pathogenesis and place among the axonal dystrophies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Choreoacanthocytosis. Clues to clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Naloxone withdrawal exacerbates Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The effects of naloxone in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The effects of sympathomimetic and antihistaminic agents on chronic motor tics and Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tics in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The Psychopathology of Gilles de la Tourette's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Involuntary movements in chorea-acanthocytosis: A comparison with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A case of post-traumatic tic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Neurobiological issues in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Familial tic disorder, parkinsonism, motor neuron disease, and acanthocytosis: a new syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Physostigmine in Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Physostigmine in Tourette syndrome: evidence for cholinergic underactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

The coexistence of tics and dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Senile-onset vocal and motor tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourette syndrome and autistic disorder: a significant relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Brief report: cases for an association between Tourette syndrome, autistic disorder, and schizophrenia-like disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Asperger's syndrome: a review of clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Cholinergic mechanisms in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

9p monosomy in a patient with Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourette-like disorder after herpes encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Nonopiate effects of dynorphin and des-Tyr-dynorphin.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Opioid therapy in the movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Linkage analysis in British and French families with idiopathic torsion dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Pancreo-pituitary hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

A compulsive movement disorder with cavitation of caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Compulsory shouting (Benedek's "klazomania") associated with oculogyric spasms in chronic epidemic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Movement disorders of familial neuroacanthocytosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

Tourette's syndrome and essential tremor in a septuagenarian

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970315-7

7 January 2021

10.1016/S0733-8619(05)70315-7

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

9115464